Equities

Vimta Labs Ltd

VIMTALABS:NSI

Vimta Labs Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)694.05
  • Today's Change119.05 / 20.70%
  • Shares traded1.02m
  • 1 Year change+67.81%
  • Beta1.0627
Data delayed at least 15 minutes, as of Nov 08 2024 10:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in INR

The one analyst offering a 12 month price target expects Vimta Labs Ltd share price to fall to 581.00 in the next year from the last price of 694.05.
High-16.3%581.00
Med-16.3%581.00
Low-16.3%581.00

Earnings history & estimates in INR

While analysts are not providing 2nd quarter earnings estimates for Vimta Labs Ltd, they are predicting full year 2025 earnings of 167.70 per share. On Nov 08, 2024, Vimta Labs Ltd reported 2nd quarter 2025 losses of -- per share.
The next earnings announcement is expected on May 12, 2025.
Average growth rate+156.27%
Vimta Labs Ltd reported annual 2024 earnings of 18.24 per share on May 18, 2024.
Average growth rate+144.88%
More ▼

Revenue history & estimates in INR

Vimta Labs Limited had revenues for the full year 2024 of 3.18bn. This was 0.02% above the prior year's results.
Average growth rate+15.76%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.